arrow
返回
M

Martin Reck

german center for lung research

88H指数
627论文数
5.3W被引数
收录论文 175
发表时间
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer From the Randomized KEYNOTE-671 StudyKEYNOTE-671研究:围手术期帕博利珠单抗治疗早期非小细胞肺癌的五年结果
err2026-08-21
err0
PREAI
errH. Wakelee; J.D. Spicer; S. Gao; M. Liberman; M. Tsuboi; T. Kato; K.-N. Chen; C. Dooms; M. Majem; G.L. Martinengo; O. Bylicki; D. Rodríguez-Abreu; B. Halmos; D.R. Jones; J.E. Chaft; M. Reck; E. Jensen; S.M. Keller; A. Samkari; M.C. Garassino
err分享
err收藏
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer改善非小细胞肺癌的新辅助和围手术期治疗
err2026-06-30
err0
PREAI
errYago Garitaonaindia; Heather A. Wakelee; Martin Reck; Patrick M. Forde; Tina Cascone; Jonathan D. Spicer; Mariano Provencio
err分享
err收藏
err分享
err收藏
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung CancerClaudin-3表达降低与非小细胞肺癌的不良肿瘤特征和不良预后相关
err2026-01-06
err0
errOAAI
errNina Schraps; Martin Reck; Birgit Hantzsch-Kuhn; Till Olchers; David Benjamin Ellebrecht; Katharina Möller; Christoph Fraune; Maximilian Lennartz; Florian Lutz; Martina Kluth; Georgia Makrypidi-Fraune; Ronald Simon; Guido Sauter; Stefan Steurer; Sönke Von Weihe
err分享
err收藏
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations非小细胞肺癌分子亚型和免疫治疗组合的脆弱性
err2025-12-03
err0
errOAAI
errTianshi Lu; Habib Hamidi; Mark A. Socinski; Martin Reck; Federico Cappuzzo; Fabrice Barlesi; Robert M. Jotte; Sören Müller; Aditi Qamra; Assaf Amitai; Xiangnan Guan; Eloisa Fuentes; Hartmut Koeppen; Jennifer M. Giltnane; David S. Shames; Marcus Ballinger; Meng Xiao He; Yulei Wang; Minu K. Srivastava; Barzin Y. Nabet
err分享
err收藏
High GLUT1 protein expression is associated with unfavorable tumor features and poor prognosis in non-small cell lung cancer高GLUT1蛋白表达与非小细胞肺癌的不良肿瘤特征和不良预后相关
err2025-11-30
err0
PREAI
errHantzsch-Kuhn, Birgit; Schraps, Nina; Reck, Martin; Olchers, Till; Ellebrecht, David Benjamin; Moeller, Katharina; Fraune, Christoph; Lennartz, Maximilian; Lutz, Florian; Kluth, Martina; Makrypidi-Fraune, Georgia; Simon, Ronald; Sauter, Guido; Steurer, Stefan
err分享
err收藏
Effectiveness of NELSON versus PLCOm2012 lung cancer screening eligibility criteria in Germany (HANSE): a prospective cohort studyNELSON与PLCOm2012肺癌筛查资格标准在德国(HANSE)中的有效性比较:一项前瞻性队列研究
err2025-11-10
err0
errOAAI
errJens Vogel-Claussen; Benjamin-Alexander Bollmann; Katharina May; Susanne Stiebeler; Sabine Dettmer; Anton Faron; Alexander Kuhlmann; Gerald Schmid-Bindert; Rudolf Kaaks; Jörg Barkhausen; Sabine Bohnet; Martin Reck
err分享
err收藏
Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671接受围手术期帕博利珠单抗治疗患者的临床特征与手术结局——KEYNOTE-671研究
err2025-11-05
err0
PREAI
errMoishe Liberman; David R. Jones; Heather Wakelee; Shugeng Gao; Balazs Halmos; Ernest Nadal; Anna Łowczak; Martin Reck; Silvia Novello; Danielli Matias; Alexander Luft; Rina Hui; Se-Hoon Lee; Masahiro Tsuboi; Terufumi Kato; Yuming Zhu; Benny Weksler; Erin Jensen; Ayman Samkari; Steven M. Keller; Jonathan D. Spicer
err分享
err收藏
White paper on identification, information, and eligibility assessment of potential participants in lung cancer screening in Germany (oct, 10.1055/a-2697-6434, 2025)德国肺癌筛查潜在参与者识别、信息与资格评估白皮书(2025年10月,10.1055/a-2697-6434)
err2025-11-01
err0
errOAAI
errBlum, Torsten Gerriet; Vogel-Claussen, Jens; Hoffmann, Hans; Reck, Martin; Harth, Volker; Faron, Anton; Danschel, Ingrid; Andreas, Stefan; Rupp, Alexander; Kaaks, Rudolf; Schmid-Bindert, Gerald
err分享
err收藏
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study一线Sacituzumab Govitecan联合Pembrolizumab治疗转移性NSCLC:EVOKE-02研究PD-L1 TPS <50%和≥50%队列
err2025-10-30
err0
PREAI
errMartin Reck; Jyoti D. Patel; Jhanelle E. Gray; Noemí Reguart; Manuel Cobo; José Fuentes Pradera; Enriqueta Felip; Federico Cappuzzo; Edward B. Garon; Joel W. Neal; Sabeen Mekan; Farnoush Safavi; Nelumka Fernando; Marianna Zavodovskaya; Juliane M. Jürgensmeier; Michael Chisamore; Byoung Chul Cho
err分享
err收藏
Distinct genomic profile of pediatric lung carcinoma: High frequency of ALK fusions and TP53 mutations compared to adults儿童肺癌的基因组特征:与成人相比,ALK融合和TP53突变频率较高
err2025-10-20
err0
errOAAI
errMichael Abele; Anton Karelin; Michaela Pogoda; Ulrike Faust; Sorin Armeanu-Ebinger; Jakob Admard; Alexandra Liebmann; Irina Bonzheim; Nicolas Waespe; Margo Hoover-Regan; Andreas Block; Martin Reck; Ewa Bien; Malgorzata Krawczyk; Dominik T. Schneider; Stephan Ossowski; Ines B. Brecht; Christopher Schroeder
err分享
err收藏
Unresectable stage III non-small-cell lung cancer: state of the art and challenges不可切除的III期非小细胞肺癌:最新进展与挑战
err2025-10-09
err0
PREAI
errJordi Remon; Antonin Levy; Romane Gille; Isabelle Martel-Lafay; Martina Bortolot; Lizza E. L. Hendriks; Corinne Faivre-Finn; Natasha Leighl; Martin Reck; Maurice Pérol
err分享
err收藏
White paper on identification, information, and eligibility assessment of potential participants in lung cancer screening in Germany关于德国肺癌筛查中潜在参与者识别、信息提供和资格评估的白皮书
err2025-10-01
err0
errOAAI
errBlum, Torsten Gerriet; Vogel-Claussen, Jens; Hoffmann, Hans; Reck, Martin; Harth, Volker; Faron, Anton; Danschel, Ingrid; Andreas, Stefan; Rupp, Alexander; Kaaks, Rudolf; Schmid-Bindert, Gerald
err分享
err收藏
Interpreting immunogenicity in oncology clinical trials在肿瘤学临床试验中解读免疫原性
err2025-08-25
err0
errOAAI
errPeter R. Galle; Martin Reck; David J. Pinato; Rosario Garcia-Campelo; Richard S. Finn; Sophie Cousin; Jim Zanghi; Coen A. Bernaards; Steven J. Swanson; Stefanie Morris; Yuan Song; Solange Peters
err分享
err收藏
Treatment of NSCLC after chemoimmunotherapy — are we making headway?化疗免疫疗法后的NSCLC治疗——我们是否取得了进展?
err2025-08-14
err0
PREAI
errMartin Reck; Nikolaj Frost; Solange Peters; Bernard A. Fox; Roberto Ferrara; Rajkumar Savai; Fabrice Barlesi
err分享
err收藏
Digital Versus Manual PD-L1 Scoring in Advanced Non-Small Cell Lung Cancer From the IMpower110 and IMpower150 Trials数字与人工PD-L1评分在晚期非小细胞肺癌中的应用比较:基于IMpower110和IMpower150试验
err2025-08-05
err0
PREAI
errRoy S. Herbst; Hen Prizant; Daniel Ruderman; Jake Conway; John Shamshoian; Hartmut Koeppen; Wei Zou; Filippo de Marinis; Giuseppe Giaccone; Jacek Jassem; David R. Spigel; Mark A. Socinski; Martin Reck; Luciana Molinero; Marcus Ballinger; David Shames; Michael Griffin; Limin Yu; Nishant Agrawal; Andrew Beck; Ilan Wapinski; Stephanie Hennek; Jennifer Giltnane; Minu K. Srivastava
err分享
err收藏
First-line nivolumab plus ipilimumab in pleural mesothelioma: Efficacy and safety data from the real-world MesoNet study一线纳武利尤单抗联合伊匹木单抗治疗恶性胸膜间皮瘤:来自真实世界MesoNet研究的疗效与安全性数据
err2025-08-05
err0
errOAAI
errRajiv Shah; Eva L. Buchmeier; Hans-Georg Kopp; Daniel C. Christoph; Frank Griesinger; Martin Reck; Petra Hoffknecht; Jonas Kuon; Nikolaj Frost; Christian Grohé; Martin Faehling; Jingting Luan; Julia Roeper; Paolo Chesi; Miriam Blasi; Martin Kimmich; Till Olchers; Helge Bischoff; Laura V. Klotz; Inn Chung; Petros Christopoulos; Michael Thomas
err分享
err收藏
Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial根据14基因表达谱被鉴定为分子高危的IA–IIA期非鳞状、非小细胞肺癌的辅助化疗(AIM-HIGH):一项国际、随机、III期临床试验
err2025-06-24
err0
errOAAI
errDavid R Spigel; Virginie Westeel; Ian C Anderson; Laurent Greillier; Florian Guisier; Olivier Bylicki; Firas B Badin; Gaelle Rousseau-Bussac; Clotilde Deldycke; Frank Griesinger; Adam Bograd; Wangjian Zhong; Jacques Le Treut; Sylvie Van Hulst; David R Gandara; Martin Reck; Petra Hoffknecht; Matthew A Gubens; John Crowley; Heiko von der Leyen; Gavitt A Woodard; David M Jablons; Johannes R Kratz; Michael J Mann
err分享
err收藏